Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?

Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?

The occurrence of the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVD-19), represents a catastrophic threat to global health. Protruding from the viral surface is a densely glycosylated spike (S) protein, which engages angiotensin-co...

Full description

Bibliographic Details
Main Authors:	Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	International Journal of Molecular Sciences
Subjects:	<b>Keywords: </b>angiotensin-converting enzyme 2 ACE2 COVID-19 c-lectin type receptor glucose-regulated protein 78 SARS-CoV-2
Online Access:	https://www.mdpi.com/1422-0067/22/3/992

Similar Items

The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease
by: Tawar Qaradakhi, et al.
Published: (2020-09-01)

The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
by: Rongrong Chen, et al.
Published: (2021-01-01)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
by: Min Shen, et al.
Published: (2020-10-01)

The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020-07-01)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
by: Graham J. Moore, et al.
Published: (2021-07-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
by: Kristen Renee McSweeney, et al.
Published: (2021-03-01)

ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
by: Sally Badawi, et al.
Published: (2021-01-01)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
by: Yixin Xie, et al.
Published: (2020-12-01)

SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
by: Christopher J. Coke, et al.
Published: (2021-01-01)

Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
by: Dean Gilham, et al.
Published: (2021-04-01)

Severe food restriction activates the central renin angiotensin system
by: Aline Maria Arlindo De Souza, et al.
Published: (2020-01-01)

Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses
by: Li Wang, et al.
Published: (2021-05-01)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
by: Federica Saponaro, et al.
Published: (2020-09-01)

The Use of ACE inhibitor/ARB in SARS-CoV-2 Patients: A Comprehensive Narrative Review
by: Timotius Ivan Hariyanto, et al.
Published: (2020-11-01)

Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
by: Michal Herman-Edelstein, et al.
Published: (2021-04-01)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
by: Thomas A. Strong, et al.
Published: (2021-12-01)

Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2
by: Reza Zolfaghari Emameh, et al.
Published: (2020-06-01)

Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2020-09-01)

Corrigendum: Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2021-05-01)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
by: Karim Bendjelid
Published: (2020-07-01)

Potential implications of SARS-CoV-2 oral infection in the host microbiota
by: Zhenting Xiang, et al.
Published: (2021-01-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

Neuropsychiatric Disorders and COVID-19: What We Know So Far
by: Fernanda Majolo, et al.
Published: (2021-09-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection
by: Giselle Santos Magalhaes, et al.
Published: (2020-06-01)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
by: Qiyue Ding, et al.
Published: (2021-02-01)

Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19
by: Polina O. Shatunova, et al.
Published: (2020-09-01)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
by: Ikram Omar Osman, et al.
Published: (2021-06-01)

Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells
by: Junping Yin, et al.
Published: (2020-12-01)

ROLE OF ANGIOTENSIN CONVERTING ENZYMES ACE AND ACE2 IN DIABETES INDUCED CARDIOVASCULAR DYSFUNCTION
by: Kanakamedala, Keerthy
Published: (2007)

Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems
by: Leila Karimi, et al.
Published: (2020-12-01)

The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
by: Juanjuan Xu, et al.
Published: (2017-05-01)

The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research
by: Alitalo, K., et al.
Published: (2022)

Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer’s disease brain
by: Yuhai Zhao, et al.
Published: (2021-10-01)

Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection
by: S. Seltzer
Published: (2020-12-01)

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
by: Brini, M., et al.
Published: (2022)

Cessation of Renin-Angiotensin System Antagonists During the SARS-CoV-2 Pandemic – Do We Have the Evidence?
by: Blîndu Emanuel, et al.
Published: (2020-09-01)

SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature
by: Daniela Fignani, et al.
Published: (2020-11-01)